Patients (n) Nasal tumors (%) Definitive RT (%) RT technique RT dose (Gy) (Dose/fraction) CTx (%) LC (%) OS (%) Cosmetic results
Katz 2002 78 62 60 Anterior and lateral fields 68 (1.8 or 1.2 twice daily) 1 60 (5yrs) 50 (5yrs) n.a.
Langendijket al. [4] 56 100 100 Opposed lateral 6MV fields +/- BT boost 67.5 (2.5) 0 80(2yrs) 66 (2yrs) n.a.
Levendaget al. [6] 64 100 78 BT 44 (3 twice daily) 0 92 (5yrs) 59 (5yrs) 65% excellent or good results (n=23)
Wallace et al. [2] 71 100 89 Anterior field MV elektrons and 6MV, BT 65-75 3 87 (5yrs) 76(5yrs) n.a.for def. treatment, poor for 6 patients and good for 2 patients treated with surgery and RT
Aggeret al. [14] 174 100 69 Opposed lateral fields 250KV or MV 54 (3) 62-66 (2) 0 67 (5yrs) 50 (5yrs) n.a.
Total 443 92 79     1 77 60  
Table 3: Summary of studies on conventionally treated patients with nasal cancer published in the IMRT era (not treated with IMRT). BT: Brachytherapy; n.a.: not assessed